Literature DB >> 23609447

Attenuated natural killer (NK) cell activation through C-type lectin-like receptor NKp80 is due to an anomalous hemi-immunoreceptor tyrosine-based activation motif (HemITAM) with impaired Syk kinase recruitment capacity.

Thomas Rückrich1, Alexander Steinle.   

Abstract

Cellular cytotoxicity is the hallmark of NK cells mediating both elimination of virus-infected or malignant cells, and modulation of immune responses. NK cytotoxicity is triggered upon ligation of various activating NK cell receptors. Among these is the C-type lectin-like receptor NKp80 which is encoded in the human Natural Killer Gene Complex (NKC) adjacent to its ligand, activation-induced C-type lectin (AICL). NKp80-AICL interaction promotes cytolysis of malignant myeloid cells, but also stimulates the mutual crosstalk between NK cells and monocytes. While many activating NK cell receptors pair with ITAM-bearing adaptors, we recently reported that NKp80 signals via a hemITAM-like sequence in its cytoplasmic domain. Here we molecularly dissect the NKp80 hemITAM and demonstrate that two non-consensus amino acids, in particular arginine 6, critically impair both hemITAM phosphorylation and Syk recruitment. Impaired Syk recruitment results in a substantial attenuation of cytotoxic responses upon NKp80 ligation. Reconstituting the hemITAM consensus or Syk overexpression resulted in robust NKp80-mediated responsiveness. Collectively, our data provide a molecular rationale for the restrained activation potential of NKp80 and illustrate how subtle alterations in signaling motifs determine subsequent cellular responses. They also suggest that non-consensus alterations in the NKp80 hemITAM, as commonly present among mammalian NKp80 sequences, may have evolved to dampen NKp80-mediated cytotoxic responses toward AICL-expressing cells.

Entities:  

Keywords:  Cell Signaling; Cell Surface Receptor; Cellular Immune Response; Immunology; Innate Immunity; NK Receptor; Natural Killer (NK) Cell; Signaling; Syk Kinase

Mesh:

Substances:

Year:  2013        PMID: 23609447      PMCID: PMC3682572          DOI: 10.1074/jbc.M113.453548

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  35 in total

1.  Dectin-1 activates Syk tyrosine kinase in a dynamic subset of macrophages for reactive oxygen production.

Authors:  David M Underhill; Eddie Rossnagle; Clifford A Lowell; Randi M Simmons
Journal:  Blood       Date:  2005-06-14       Impact factor: 22.113

Review 2.  New experimental approaches in retrovirus-mediated expression screening.

Authors:  T Kitamura
Journal:  Int J Hematol       Date:  1998-06       Impact factor: 2.490

Review 3.  Syk-coupled C-type lectin receptors that mediate cellular activation via single tyrosine based activation motifs.

Authors:  Ann M Kerrigan; Gordon D Brown
Journal:  Immunol Rev       Date:  2010-03       Impact factor: 12.988

4.  Catalytic specificity of protein-tyrosine kinases is critical for selective signalling.

Authors:  Z Songyang; K L Carraway; M J Eck; S C Harrison; R A Feldman; M Mohammadi; J Schlessinger; S R Hubbard; D P Smith; C Eng
Journal:  Nature       Date:  1995-02-09       Impact factor: 49.962

5.  Characterization of genetically altered, interleukin 2-independent natural killer cell lines suitable for adoptive cellular immunotherapy.

Authors:  Y K Tam; G Maki; B Miyagawa; B Hennemann; T Tonn; H G Klingemann
Journal:  Hum Gene Ther       Date:  1999-05-20       Impact factor: 5.695

6.  Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA.

Authors:  S Bauer; V Groh; J Wu; A Steinle; J H Phillips; L L Lanier; T Spies
Journal:  Science       Date:  1999-07-30       Impact factor: 47.728

7.  Molecular and functional characterization of NKG2D, NKp80, and NKG2C triggering NK cell receptors in rhesus and cynomolgus macaques: monitoring of NK cell function during simian HIV infection.

Authors:  Roberto Biassoni; Manuela Fogli; Claudia Cantoni; Paola Costa; Romana Conte; Gerrit Koopman; Aurelio Cafaro; Barbara Ensoli; Alessandro Moretta; Lorenzo Moretta; Andrea De Maria
Journal:  J Immunol       Date:  2005-05-01       Impact factor: 5.422

8.  Identification of NKG2A and NKp80 as specific natural killer cell markers in rhesus and pigtailed monkeys.

Authors:  Domenico Mavilio; Janet Benjamin; Diana Kim; Gabriella Lombardo; Marybeth Daucher; Audrey Kinter; Elizabeth Nies-Kraske; Emanuela Marcenaro; Alessandro Moretta; Anthony S Fauci
Journal:  Blood       Date:  2005-05-17       Impact factor: 22.113

9.  Dectin-1 uses novel mechanisms for yeast phagocytosis in macrophages.

Authors:  Jurgen Herre; Andrew S J Marshall; Emmanuelle Caron; Alexander D Edwards; David L Williams; Edina Schweighoffer; Victor Tybulewicz; Caetano Reis e Sousa; Siamon Gordon; Gordon D Brown
Journal:  Blood       Date:  2004-08-10       Impact factor: 22.113

10.  Identification of NKp80, a novel triggering molecule expressed by human NK cells.

Authors:  M Vitale; M Falco; R Castriconi; S Parolini; R Zambello; G Semenzato; R Biassoni; C Bottino; L Moretta; A Moretta
Journal:  Eur J Immunol       Date:  2001-01       Impact factor: 5.532

View more
  4 in total

1.  The Activating C-type Lectin-like Receptor NKp65 Signals through a Hemi-immunoreceptor Tyrosine-based Activation Motif (hemITAM) and Spleen Tyrosine Kinase (Syk).

Authors:  Björn Bauer; Tanja Wotapek; Tobias Zöller; Emilia Rutkowski; Alexander Steinle
Journal:  J Biol Chem       Date:  2017-01-12       Impact factor: 5.157

Review 2.  Recognition of tumors by the innate immune system and natural killer cells.

Authors:  Assaf Marcus; Benjamin G Gowen; Thornton W Thompson; Alexandre Iannello; Michele Ardolino; Weiwen Deng; Lin Wang; Nataliya Shifrin; David H Raulet
Journal:  Adv Immunol       Date:  2014       Impact factor: 3.543

Review 3.  Modulation of NK cell function by genetically coupled C-type lectin-like receptor/ligand pairs encoded in the human natural killer gene complex.

Authors:  Yvonne Bartel; Björn Bauer; Alexander Steinle
Journal:  Front Immunol       Date:  2013-11-07       Impact factor: 7.561

Review 4.  Taking Lessons from CAR-T Cells and Going Beyond: Tailoring Design and Signaling for CAR-NK Cells in Cancer Therapy.

Authors:  Katharina Eva Ruppel; Stephan Fricke; Ulrike Köhl; Dominik Schmiedel
Journal:  Front Immunol       Date:  2022-03-18       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.